Menu
1-702-720-6310 info@microcapspecualtors.com

Biotech Movers: Exelixis, Omeros, Inovio – TheStreet.com


TheStreet.com

Biotech Movers: Exelixis, Omeros, Inovio
TheStreet.com
Shares of Exelixis Inc. (EXEL) rose 1.9% to $25.70 in premarket trading on Monday, July 10, after the South San Francisco, Calif.-based firm and Bristol-Myers Squibb Co. (BMY) announced they have started a Phase 3 study of Opdivo (nivolumab) in tandem …

and more »

Search